Neutra Corp. (OTCBB: NTRR), an emerging provider of innovative nutraceuticals, announced today that it is one step closer to delivering its revolutionary Pure Plus weight-loss supplement to market.
The company has chosen a manufacturer that adheres to its rigid standards for purity and quality of ingredients. Next, NTRR will place its first order for its debut product offering. The first test batch of weight-loss supplements that the company receives will be earmarked for upcoming clinical trials.
Pure Plus products will feature a unique Bio-energy infusion expected to significantly increase the effectiveness of each all-natural ingredient in the formulation, maximizing their performance naturally. Plans call for each batch of supplements to be sent from the manufacturer to the Bio-energy laboratory for this specialized infusion before final delivery to NTRR.
Testing will begin on volunteer subjects within the next 30 days.
Neutra Corp. is developing new products to compete in the rising nutraceuticals industry alongside Mannatech, Inc. (NASDAQ: MTEX), Nutraceutical International Corp. (NASDAQ: NUTR), Herbalife Ltd. (NYSE: HLF), and Schiff Nutrition International Inc. (NYSE: WNI).
For more information on NTRR’s nutraceuticals initiative, please visit www.neutracorp.com/investors.
Follow NTRR on Twitter at www.twitter.com/neutracorp.
About Neutra Corp.
Neutra Corp. (www.neutracorp.com) is a healthy lifestyle company that specializes in the development and marketing of nutritional supplements, nutrient boosters, herbal remedies and other natural wellness solutions. The company is currently working to produce a full range of products to address every component of a healthy lifestyle, including muscle building, weight loss and general wellness through a daily nutrition regimen. For investing information and performance data, please visit www.neutracorp.com/investors.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.
